| # | Drug | Count |
|---|---|---|
| 0 | ANTIHEMOPHILIC FACTOR (RECOMBINANT) | 12 |
| 1 | SILDENAFIL | 6 |
| 2 | SILDENAFIL CITRATE | 6 |
| 3 | SILDENAFIL POWDER, | 5 |
| 4 | ANTIHEMOPHILIC FACTOR RECOMBINANT | 4 |
| 5 | DABIGATRAN ETEXILATE | 3 |
| 6 | DABIGATRAN ETEXILATE MESYLATE | 3 |
| 7 | ALEMTUZUMAB | 2 |
| 8 | GABAPENTIN | 2 |
| 9 | 0XYGEN | 1 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | ANTIHEMOPHILIC FACTOR (RECOMBINANT), PORCINE SEQUENCE | 1 | 0.0065 |
| 1 | ANTIHEMOPHILIC FACTOR (RECOMBINANT) | 12 | 0.0014 |
| 2 | ANTIHEMOPHILIC FACTOR/VON WILLEBRAND FACTOR COMPLEX (HUMAN) | 1 | 0.0009 |
| 3 | COAGULATION FACTOR VIIA (RECOMBINANT) | 1 | 0.0004 |
| 4 | ANTIHEMOPHILIC FACTOR (RECOMBINANT), FC FUSION PROTEIN | 1 | 0.0003 |
| 5 | SILDENAFIL POWDER, | 5 | 0.0001 |
| 6 | TRANEXAMIC ACID | 1 | 0.0001 |
| 7 | ALEMTUZUMAB | 2 | 0.0001 |
| 8 | EVEROLIMUS TABLETS | 1 | 0.0001 |
| 9 | SILDENAFIL CITRATE | 6 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | CD52-directed Cytolytic Antibody [EPC] | 2 | 0.0001 |
| 2 | Antifibrinolytic Agent [EPC] | 1 | 0.0001 |
| 3 | Phosphodiesterase 5 Inhibitor [EPC] | 5 | 0.0000 |
| 4 | Antirheumatic Agent [EPC] | 1 | 0.0000 |
| 5 | Angiotensin Converting Enzyme Inhibitor [EPC] | 1 | 0.0000 |
| 6 | Aldosterone Antagonist [EPC] | 1 | 0.0000 |
| 7 | Opioid Agonist [EPC] | 1 | 0.0000 |
| 8 | Folate Analog Metabolic Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Insulin Analog [EPC] | 1 | 0.0000 |